1 University of Florida Health Jacksonville, FL, USA.
Ann Pharmacother. 2019 Oct;53(10):1033-1041. doi: 10.1177/1060028019849716. Epub 2019 May 3.
Recent literature suggests that intravenous (IV) administration may cause hypotension in hospitalized patients; data further suggest that this effect is most pronounced in the critically ill. The purpose of this review is to identify and evaluate current literature that addresses the incidence and implications of IV acetaminophen-induced hypotension. A literature search of MEDLINE, Cochrane, and EMBASE databases was performed (2002-2019) using the following terms: , and . Abstracts and peer-reviewed publications were reviewed. Relevant English-language studies conducted in humans evaluating the hemodynamic effects of IV acetaminophen were considered. : A majority of the 19 studies included in this review identified a statistically significant drop in hemodynamic variables after the administration of 500 to 1000 mg IV acetaminophen as measured by changes in systolic blood pressure, diastolic blood pressure, or mean arterial pressure. Of the trials reporting vasopressor use, the authors found a significant increase in vasopressor requirements following IV acetaminophen administration. This review represents the first comprehensive review of IV acetaminophen-induced hypotension. The findings raise the question of whether IV acetaminophen is an appropriate choice for inpatient pain or temperature management in the critically ill. Available evidence indicates that the administration of IV acetaminophen may be harmful in the critically ill. Additional monitoring is likely required when using IV acetaminophen in this specific population, particularly if a patient is hemodynamically unstable prior to administration.
近期文献表明,静脉(IV)给药可能会导致住院患者出现低血压;有数据进一步表明,这种效应在危重症患者中最为明显。本综述的目的是确定和评估当前关于静脉用对乙酰氨基酚引起低血压的发生率和影响的文献。通过 MEDLINE、Cochrane 和 EMBASE 数据库进行了文献检索(2002-2019 年),使用了以下术语:,和。对摘要和同行评议的出版物进行了审查。考虑了评估静脉用对乙酰氨基酚对血流动力学影响的以人类为对象的相关英文研究。:本综述中纳入的 19 项研究中的大多数研究表明,在给予 500 至 1000 毫克静脉用对乙酰氨基酚后,通过收缩压、舒张压或平均动脉压的变化,确定了血流动力学变量有统计学意义的下降。在报告使用血管加压药的试验中,作者发现,在给予静脉用对乙酰氨基酚后,对血管加压药的需求显著增加。本综述代表了对静脉用对乙酰氨基酚引起的低血压的首次全面综述。这些发现提出了一个问题,即对于危重症患者的住院疼痛或体温管理,静脉用对乙酰氨基酚是否是一个合适的选择。现有证据表明,在危重症患者中,给予静脉用对乙酰氨基酚可能是有害的。在该特定人群中使用静脉用对乙酰氨基酚时,可能需要进行额外的监测,特别是如果患者在给药前血流动力学不稳定。